News zu Celyad Oncology
Celyad Oncology Announces Clinical Hold of CYAD-101-002 Phase 1b Trial · Uhr · Business Wire
Celyad Oncology Announces Voluntary Pause of CYAD-101-002 Phase 1b Trial · Uhr · Business Wire
Celyad Oncology Announces February 2022 Conference Schedule · Uhr · Business Wire
Celyad Oncology Provides Outlook for 2022 · Uhr · Business Wire
Celyad Oncology Announces January 2022 Conference Schedule · Uhr · Business Wire
Celyad Oncology Announces $32.5 Million Private Placement With Fortress Investment Group · Uhr · Business Wire
Celyad Oncology Announces November 2021 Conference Schedule · Uhr · Business Wire